Form 4: Trupanion CFO Fawwad Qureshi Reports Stock Transactions
SEC Form 4
Fawwad Qureshi, CFO of Trupanion, Inc., reports the vesting and conversion of restricted stock units into common stock, along with shares withheld for tax obligations.
Summary
- On February 24, 2025, Fawwad Qureshi, the CFO of Trupanion, Inc., reported transactions involving common stock and restricted stock units (RSUs).
- Qureshi converted 913 RSUs into common stock and then disposed of 330 shares to cover income tax withholding at a price of $33.41 per share, resulting in a net increase of 583 shares.
- Additionally, 1,250 RSUs were converted into common stock, with 460 shares withheld for taxes at $33.41 per share, leading to a net increase of 790 shares.
- Following these transactions, Qureshi directly owns 1,373 shares of common stock and holds 3,750 RSUs.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the document simply reports routine stock transactions by a company executive. There are no explicit positive or negative implications for the company's performance.
Positives
- The vesting of RSUs indicates a form of compensation and alignment of the CFO's interests with the company's performance.
Negatives
- The sale of shares to cover tax obligations, while standard, slightly reduces the CFO's direct holdings in the company.
Risks
- There are no specific risks highlighted in this document, as it primarily reports stock transactions.
Future Outlook
The document does not contain any specific forward-looking statements about the company's future performance.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. It's a standard practice across publicly traded companies.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading.
- The vesting schedules and RSU grants are typical compensation methods used to align executive interests with shareholder value, similar to practices at companies like PetMed Express and Zoetis.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| February 27, 2024 | Reporting person was granted 7,304 restricted stock units (RSUs). |
| February 27, 2024 | Reporting person was granted 5,000 restricted stock units (RSUs). |
| May 22, 2024 | 1/8th of the 7,304 RSUs vest. |
| February 24, 2025 | Date of reported transactions: conversion of RSUs to common stock and withholding of shares for tax obligations. |
| February 25, 2025 | 1/4th of the 5,000 RSUs vest. |
| February 22, 2026 | Expiration date for some of the Restricted Stock Units (RSU). |
| February 25, 2028 | Expiration date for some of the Restricted Stock Units (RSU). |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.